Tunisia, WHO Seek Scaled-Up Cooperation in Pharmaceuticals, Vaccine Production

Tunis, May 29 — Scaled-up technical cooperation between Tunisia and the World Health Organisation (WHO) was discussed at a working session held Wednesday on the sidelines of the 77th session of the World Health Assembly (WHA) in Geneva, Switzerland.

This covers the national pharmaceutical industry and vaccine production, in particular, through available funding lines.

The working session was attended by Health Minister Ali Mrabet, WHO Envoy for Multilateral Affairs at the Office of the Director General Stéphanie Seydoux and Coordinator of mRNA technology transfer programme for Tunisia Martin Friede.

The possibility of organising joint events to spotlight the recommendations of the Djerba Declaration in the health setor, in collaboration with the WHO and the The International Organisation of La Francophonie, was raised, mainly in connection to e-health and equal access to healthcare.

This follows the Francophone meeting on the mRNA Technology Transfer Programme held on October 27, 2023, under Tunisia's chairmanship and with attendance of WHO Director General.

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.